Published Apr 1, 2017



PLUMX
Almetrics
 
Dimensions
 

Google Scholar
 
Search GoogleScholar


Mary García Acero

Silvia Plata

##plugins.themes.bootstrap3.article.details##

Abstract

Introduction: Congenital anomalies are a structural or functional alteration with impact on infant morbidity and mortality and disability worldwide. Strategies aimed to reduce their impact are supported by surveillance systems. In Colombia, since 2010 the report of congenital anomalies was included in the surveillance system (Sivigila). Aim: To characterize epidemiologically the notification of the event from its inclusion. Materials and methods: Is carried out descriptive analysis of the events reported during January of 2010 to December of 2013. Results: We found a prevalence of congenital malformations of 0.35% in Colombia during the analyzed period. The congenital anomalies with more frequent notification were those of the central nervous system and the anomalies of limbs. Conclusions: The prevalence reported for congenital malformations in Colombia is low compared to that reported in the literature that is between 3.0-7.0% of the population. The low rate of notification for congenital anomalies evidence the need for training to improve the notification of this event, to have a record closer to the reality of the population and thus be able to take decisions for the benefit of the population and in the generation of knowledge on this topic.

Keywords

congenital anomalies, congenital malformations, notification, epidemiological surveillance.anomalías congénitas, malformaciones congénitas, notificación, vigilancia epidemiológica

References
1. Moore K. The Developing human: clinically orientated embryology. Philadelphia: Saunders; 2003.
2. Departamento Administrativo Nacional de Estadística (DANE). Indicador de seguimiento de economía [Internet]. [citado 2015 feb 18]. Disponible en: http://www.dane.gov.co/index.php/poblacion-y-registros-vitales/nacimientos-y-defunciones/nacimientos-y-defunciones/118-demograficas/estadisticas-vitales/2863-defunciones-no-fetales-2012-preliminar
3. Pan American Health Organization. Leading causes of deaht [internet]. [citado 2015 feb 18]. Disponible en: http://ais.paho.org/phip/viz/mort_causasprincipales_lt_oms.asp
4. Christianson A, Howson CP, Modell B. Global report on birth defects: The hidden toll of dying and disabled children [Internet]. Executive Summary March of Dimes. Global report on birth defects; 2006. Disponible en: http://www.marchofdimes.com/globalreport1
5. Bernal J, Zarante I. Malformations and congenital anomalies: Impact and future. Biomédica [Internet]. 2009 [citado 2015 feb 18];29(1):7-8. Disponible en:1. Moore K. The Developing human: clinically orientated embryology. Philadelphia: Saunders; 2003.
2. Departamento Administrativo Nacional de Estadística (DANE). Indicador de seguimiento de economía [Internet]. [citado 2015 feb 18]. Disponible en: http://www.dane.gov.co/index.php/poblacion-y-registros-vitales/nacimientos-y-defunciones/nacimientos-y-defunciones/118-demograficas/estadisticas-vitales/2863-defunciones-no-fetales-2012-preliminar
3. Pan American Health Organization. Leading causes of deaht [internet]. [citado 2015 feb 18]. Disponible en: http://ais.paho.org/phip/viz/mort_causasprincipales_lt_oms.asp
4. Christianson A, Howson CP, Modell B. Global report on birth defects: The hidden toll of dying and disabled children [Internet]. Executive Summary March of Dimes. Global report on birth defects; 2006. Disponible en: http://www.marchofdimes.com/globalreport1
5. Bernal J, Zarante I. Malformations and congenital anomalies: Impact and future. Biomédica [Internet]. 2009 [citado 2015 feb 18];29(1):7-8. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-41572009000100001&lng=en&nrm=iso&tlng=es
6. Lenz W. A short history of thalidomide embryopathy. Teratology [internet]. 1988 Sep [citado 2015 Feb 18];38(3):203-15. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/3067415
7. Reefhuis J, de Jong-van den Berg LTW, Cornel MC. The use of birth defect registries for etiological research: a review. Community Genet [Internet]. 2002 Jan [citado 2015 mar 10];5(1):13-32. Disponible en: http://www.karger.com/Article/FullText/64628
8. Palacio Betancourt D, Uribe Vélez A. Plan Nacional de Salud Pública 2007-2010 [internet]. Decreto 3039. Plan Nacional de Salud Pública; 2007. Disponible en: http://new.paho.org/hq/dmdocuments/2010/Politicas_Nacionales_Salud-Colombia_2007-2010.pdf
9. González González Y. Informe final del evento anomalías congénitas hasta el periodo epídemiológico 13 del año 2012 [internet]. Instituto Nacional de Salud; 2015 [citado 2015 feb 18]. Disponible en: http://www.ins.gov.co/lineas-de-accion/Subdireccion-Vigilancia/Informe de Evento Epidemiolgico/ANOMALI %CC %81AS CONGE %CC %81NITAS 2012.pdf
10. Grupo de Vigilancia y Control de Enfermedades no Transmisibles. Protocolo de vigilancia y control de anomalías congénitas [internet]. Instituto Nacional de Salud; 2009 [citado 2015 feb 18]. Disponible en: http://www.saludcordoba.gov.co/portal/descargas/sivigila2010/cronicas-no-transmisibles/ANOMALIAS_CONGENITAS.pdf
11. Zarante I. Anomalías congénitas [internet]. Disponible en: http://www.anomaliascongenitas.org/app/webroot/blog/?page_id=9.
12. Won Ireland J. Common Chromosomal disorders. En: Case based pediatrics for medical students and residents department of pediatrics. University of Hawaii John A Burns; 2003.
13. Zarante I, Franco L, López C, Fernández N. Frecuencia de malformaciones congénitas : evaluación y pronóstico de 52.744 nacimientos en tres ciudades colombianas. Biomédica. 2010;30:65-71.
14. García H, Salguero GA, Moreno J, Arteaga C, Giraldo A. Frecuencia de anomalías congénitas en el Instituto Materno Infantil de Bogotá. Biomédica [Internet]. 2003 [citado 2015 mar 10];23(2):161-72. Disponible en: http://www.redalyc.org/resumen.oa?id=84323206
15. Pachajoa H, Ariza Y, Isaza C. Defectos congénitos mayores en un hospital de tercer nivel en Cali, Colombia 2004-2008. Rev Salud Púb. 2011;13(1):152-62.
How to Cite
García Acero, M., & Plata, S. (2017). Characterization of Congenital Anomalies since Inclusion in the Sivigila Surveillance System in Colombia, 2010-2013. Universitas Medica, 58(1). https://doi.org/10.11144/Javeriana.umed58-1.caci
Section
Original Articles

Most read articles by the same author(s)